Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Leukemia. 2014 Nov 3;29(4):939–946. doi: 10.1038/leu.2014.310

Figure 6. IL-35 serum levels were reduced in aGVHD patients.

Figure 6

(A) The percentages of Tregs were evaluated in patients with aGVHD grade 0-1 and aGVHD grade 2-4. (B) IL-35 serum level was measured and compared between aGVHD grade 0-1 and aGVHD grade 2-4 patients. (C) Correlation between the percentage of Tregs and serum level of IL-35 was analyzed. * p<0.05, ** p<0.01.